Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Biotech Acquisition Company/ 8-K

Current Report · 8-K

Biotech Acquisition Company

Current Report

Filed Feb 2, 2023Accepted Feb 1, 2023, 3:00 PM ESTCIK 1825413Accession 0001213900-23-006840
View company →Permanent SEC source ↗
Share

Company context

Historical securities (3)
BIOTOTC · EQUITY · Historical · closed Feb 2, 2023BIOTUNASDAQ · UNIT · Historical · closed Feb 2, 2023BIOTWNASDAQ · WARRANT · Historical · closed Feb 2, 2023

Recent company filings

  1. 15-12G filingFeb 14, 2023
  2. SC 13G/A filingFeb 14, 2023
  3. SC 13G/A filingFeb 13, 2023
  4. 25-NSE filingFeb 2, 2023
  5. 8-K filingJan 25, 2023